BioSpace News Archive

Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma” or the “Company”) today announced dosing of the first patient in a registrational Phase 3 clinical trial of ampreloxetine (TD-9855) in patients with symptomatic neurogenic orthostatic hypotension (nOH).

In response to this upward trend, leading sobriety coach Craig Beck is bringing his live Quit Drinking Bootcamp to Toronto, Canada.

Alivio to receive up to $14.75 million in upfront and near-term license exercise payments and is eligible to receive royalties on product sales and over $260 million in research and development milestones

NeoPharm, the fastest-growing pharmaceutical company in Bulgaria, announced that it now has Ultimate Joint Elements and Supreme Probiotic Elements live on Amazon.

Redsense Medical announces that the company has started the development of a prototype with fully functional optical measuring based on the innovative, smart wound technology that was presented in November 2018.

LabFinder.com has announced its partnership with local NYC non-profit, Project Sunshine, to reach and enrich the lives of pediatric patients in hospitals and other medical facilities.

Integrated network matches at-risk community with unique prevention program

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces the availability of research-use-only (RUO) kits, which are intended to enable molecular laboratories around the world to utilize Biocept’s Target Selector

Twist Bioscience Corporation today announced that it will issue its financial results for the fiscal 2019 first quarter ended Dec. 31, 2018

Masimo (NASDAQ: MASI) announced today FDA clearance of the measurement of respiration rate from the pleth (RRp®) on the MightySat™ Rx spot-check fingertip pulse oximeter, as well as its indication for use in the home environment.